Study aims to find treatment for incurable lung condition

A study into Idiopathic Pulmonary Fibrosis (IPF) – a currently incurable but increasingly common condition – has recruited its one-hundredth participant. The clinical trial, funded by the EME Programme, an MRC and NIHR partnership, is the largest non-commercial drug trial for IPF in the UK and spans 35 NHS trusts across the country. IPF is...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news